Systasy Bioscience
Systasy Bioscience GmbH is a technology provider specializing in hyper-multiplexed drug discovery solutions, particularly for complex brain disorders. Their proprietary DNA barcoding technology enables highly multiplexed transcriptomic analysis at the single-cell level, facilitating collaboration with partners in the pharmaceutical and biotech industries. By leveraging patient-derived disease models and AI-driven insights, Systasy aims to enhance the drug discovery pipeline, from target identification to patient stratification, ultimately increasing the success rate of drug development and addressing unmet medical needs in brain disorders. Founded in 2012, Systasy is positioned to revolutionize treatment strategies and improve global health outcomes.
Systasy Bioscience
Systasy Bioscience GmbH is a technology provider specializing in hyper-multiplexed drug discovery solutions, particularly for complex brain disorders. Their proprietary DNA barcoding technology enables highly multiplexed transcriptomic analysis at the single-cell level, facilitating collaboration with partners in the pharmaceutical and biotech industries. By leveraging patient-derived disease models and AI-driven insights, Systasy aims to enhance the drug discovery pipeline, from target identification to patient stratification, ultimately increasing the success rate of drug development and addressing unmet medical needs in brain disorders. Founded in 2012, Systasy is positioned to revolutionize treatment strategies and improve global health outcomes.